PURPOSE: The objective of this study was to provide direct evidence of the relative importance of the His57 residue present in transmembrane domain 2 (TMD 2) and the His121 residue in TMD 4 as proton-binding sites in human PepT1 (hPepT1) by using a novel mutagenesis approach. METHODS: His57 and His121 in hPepT1 were each mutated to alanine, arginine, or lysine individually to obtain H57A-, H57R-, H57K-, H121A-, H121R-, and H121K-hPepT1. H7A-hPepT1 was used as a negative control. [3H]Glycylsarcosine (Gly-Sar) uptake was measured 72 h posttransfection using HEK293 cells individually transfected with these mutated proteins. Steady-state I/V curves (-150 mV to +50 mV, holding potential -70 mV) were obtained by measuring 5 mM Gly-Sar-induced currents in oocytes expressing H-57R- and H57K-hPepT1. Noninjected oocytes and wild-type hPepT1 (WT-hPepT1)-injected oocytes served as negative and positive controls, respectively. RESULTS: At pH 6.0, H57K-, H57R-, H121K-, and H121R-hPepT1 led to a 97%, 90%, 45%, and 75% decrease in [3H]Gly-Sar uptake into HEK293 cells, respectively. At pH 7.4, uptake in cells transfected with H57K- and H57R-hPepT1 was not significantly different from that at pH 6.0, whereas cells expressing H121R- and H121K-hPepT1 showed 56% and 65% decrease, respectively, compared to that at pH 6.0. In oocytes expressing H57R-hPepT1, steady-state currents induced by 5 mM Gly-Sar increased with increasing pH (I(max) = 300 nA at pH 8.5), suggesting the binding of protons to H57R. No such trend was observed in oocytes injected with H57K, H121R, and H121K cRNA. CONCLUSIONS: H57R-hPepT1 is able to bind protons at a relatively basic pH, resulting in facilitation of transport of Gly-Sar by hPepT1 at higher pH. Our novel approach provides direct evidence that His57 is a principal proton-binding site in hPepT1.
PURPOSE: The objective of this study was to provide direct evidence of the relative importance of the His57 residue present in transmembrane domain 2 (TMD 2) and the His121 residue in TMD 4 as proton-binding sites in humanPepT1 (hPepT1) by using a novel mutagenesis approach. METHODS:His57 and His121 in hPepT1 were each mutated to alanine, arginine, or lysine individually to obtain H57A-, H57R-, H57K-, H121A-, H121R-, and H121K-hPepT1. H7A-hPepT1 was used as a negative control. [3H]Glycylsarcosine (Gly-Sar) uptake was measured 72 h posttransfection using HEK293 cells individually transfected with these mutated proteins. Steady-state I/V curves (-150 mV to +50 mV, holding potential -70 mV) were obtained by measuring 5 mM Gly-Sar-induced currents in oocytes expressing H-57R- and H57K-hPepT1. Noninjected oocytes and wild-type hPepT1 (WT-hPepT1)-injected oocytes served as negative and positive controls, respectively. RESULTS: At pH 6.0, H57K-, H57R-, H121K-, and H121R-hPepT1 led to a 97%, 90%, 45%, and 75% decrease in [3H]Gly-Sar uptake into HEK293 cells, respectively. At pH 7.4, uptake in cells transfected with H57K- and H57R-hPepT1 was not significantly different from that at pH 6.0, whereas cells expressing H121R- and H121K-hPepT1 showed 56% and 65% decrease, respectively, compared to that at pH 6.0. In oocytes expressing H57R-hPepT1, steady-state currents induced by 5 mM Gly-Sar increased with increasing pH (I(max) = 300 nA at pH 8.5), suggesting the binding of protons to H57R. No such trend was observed in oocytes injected with H57K, H121R, and H121K cRNA. CONCLUSIONS:H57R-hPepT1 is able to bind protons at a relatively basic pH, resulting in facilitation of transport of Gly-Sar by hPepT1 at higher pH. Our novel approach provides direct evidence that His57 is a principal proton-binding site in hPepT1.
Authors: A K Yeung; S K Basu; S K Wu; C Chu; C T Okamoto; S F Hamm-Alvarez; H von Grafenstein; W C Shen; K J Kim; M B Bolger; I S Haworth; D K Ann; V H Lee Journal: Biochem Biophys Res Commun Date: 1998-09-08 Impact factor: 3.575
Authors: Fiona E Baird; Jorge J Pinilla-Tenas; William L J Ogilvie; Vadival Ganapathy; Harinder S Hundal; Peter M Taylor Journal: Biochem J Date: 2006-07-15 Impact factor: 3.857
Authors: Nanda G Aduri; Bala K Prabhala; Heidi A Ernst; Flemming S Jørgensen; Lars Olsen; Osman Mirza Journal: J Biol Chem Date: 2015-10-19 Impact factor: 5.157
Authors: Simon Newstead; David Drew; Alexander D Cameron; Vincent L G Postis; Xiaobing Xia; Philip W Fowler; Jean C Ingram; Elisabeth P Carpenter; Mark S P Sansom; Michael J McPherson; Stephen A Baldwin; So Iwata Journal: EMBO J Date: 2010-12-03 Impact factor: 11.598
Authors: Ashutosh A Kulkarni; Daryl L Davies; Jennifer S Links; Leena N Patel; Vincent H L Lee; Ian S Haworth Journal: Pharm Res Date: 2006-09-29 Impact factor: 4.580
Authors: Joep Schothorst; Harish Nag Kankipati; Michaela Conrad; Dieter R Samyn; Griet Van Zeebroeck; Yulia Popova; Marta Rubio-Texeira; Bengt L Persson; Johan M Thevelein Journal: Curr Genet Date: 2013-10-11 Impact factor: 3.886